O. Coban et al., Masked assessment of MRI findings: is it possible to differentiate neuro-Behcet's disease from other central nervous system, NEURORADIOL, 41(4), 1999, pp. 255-260
Two neuroradiologists reviewed MRI studies of 34 patients with neuro-Behcet
's disease (NBD), 22 with multiple sclerosis (MS) and 7 with systemic lupus
erythematosus (SLE) with central nervous system involvement, masked to the
clinical diagnosis, age and sex of the patients. Of the patients with NBD
12 were in an acute attack; the others had chronic disease. MRI was assesse
d using a set of criteria, looking at atrophy, the site of discrete parench
ymal lesions, regions of predominant involvement and the extent of the lesi
on(s). The observers also made a guess at the clinical diagnosis. The brain
stem and/or basal ganglia were the most predominantly involved sites in al
l patients with acute NBD; 75% of these lesions were large and confluent, m
ainly extending from the brain stem to the diencephalon and basal ganglia.
However, in chronic cases, the predominant involvement was in the brain ste
m and/or basal,ganglia in only 36%, and in cerebral hemisphere white matter
in another 36%; 27% of these patients showed no parenchymal lesion. Hemisp
here white-matter lesions were equally distributed between periventricular
and other areas in NBD, while in MS more were periventricular, and in SLE m
ore were nonperiventricular. Brain-stem atrophy was seen in 21% of patients
with NBD, with a specificity of 96.5%. In the absence of cortical atrophy,
its specificity was 100%. The attempt at making a radiological diagnosis w
as successful in all cases of acute NBD and 95.5% of patients with MS, but
in only 40% of patients with chronic NBD. Most of this latter groups MRI st
udies were interpreted as MS. An extensive lesion involving the brain stem
and basal ganglia seemed to be diagnostic of acute NBD. However, hemisphere
white-matter lesions could not be differentiated from those in MS.